Akero Therapeutics (AKRO) had the highest return between April 1, 2022 and November 30, 2022 by a mid-cap US stock, returning 224.3%.
| ASSET | DATE | % RETURN |
|---|---|---|
Akero Therapeutics (AKRO) | 4/1/2022 - 11/30/2022 | 224.27% |
Biohaven Pharmaceutical (BHVN) | 4/1/2022 - 11/30/2022 | 163.67% |
Verona Pharma PLC ADR (VRNA) | 4/1/2022 - 11/30/2022 | 154.94% |
Nuvalent (NUVL) | 4/1/2022 - 11/30/2022 | 137.06% |
Immunovant (IMVT) | 4/1/2022 - 11/30/2022 | 136.22% |
New Oriental Education & Technology (EDU) | 4/1/2022 - 11/30/2022 | 133.66% |
Rhythm Pharmaceuticals (RYTM) | 4/1/2022 - 11/30/2022 | 132.99% |
Modine Manufacturing (MOD) | 4/1/2022 - 11/30/2022 | 131.62% |
F&G Annuities & Life (FG) | 4/1/2022 - 11/30/2022 | 129.9% |
TransMedics (TMDX) | 4/1/2022 - 11/30/2022 | 128.3% |
ELF Beauty (ELF) | 4/1/2022 - 11/30/2022 | 110.33% |
Celsius (CELH) | 4/1/2022 - 11/30/2022 | 101.37% |
Catalyst Pharmaceuticals (CPRX) | 4/1/2022 - 11/30/2022 | 101.08% |
Impinj (PI) | 4/1/2022 - 11/30/2022 | 99.08% |
Vaxcyte (PCVX) | 4/1/2022 - 11/30/2022 | 89.86% |
Griffon (GFF) | 4/1/2022 - 11/30/2022 | 89.5% |
TAL Education (TAL) | 4/1/2022 - 11/30/2022 | 87.15% |
ADMA Biologics (ADMA) | 4/1/2022 - 11/30/2022 | 82.51% |
Hafnia (HAFN) | 4/1/2022 - 11/30/2022 | 81.71% |
Axsome Therapeutics (AXSM) | 4/1/2022 - 11/30/2022 | 72.86% |
Huron Consulting (HURN) | 4/1/2022 - 11/30/2022 | 70.33% |
H&R Block (HRB) | 4/1/2022 - 11/30/2022 | 69.53% |
Calix (CALX) | 4/1/2022 - 11/30/2022 | 66.36% |
Sylvamo (SLVM) | 4/1/2022 - 11/30/2022 | 63.55% |
Sanmina (SANM) | 4/1/2022 - 11/30/2022 | 62.94% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
